Market Updates

Lonza Signs Supply Agreement with EVA Pharma

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Egypt-based EVA Pharma and Lonza, Basel, Switzerland, have signed a multi-year supply agreement for Carnipure tartrate and Carnipure crystalline, two of Lonza’s L-carnitine products, as well as a Carnipure brand licensing agreement.

EVA Pharma’s Carnivita Forte is an over-the-counter product intended for men looking to promote their fertility by increasing sperm count and sperm motility. The product contains 1 gram of Carnipure tartrate per tablet. L-carnitine is a nutrient that plays an important role in fat and energy metabolism. Organs and cells with high energy demands, such as sperm, contain high levels of L-carnitine.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters